4ª Edição

Nivolumab has a positive impact on overall survival in patients with refractory esophageal cancer

per: Grupo Oncoclínicas
Nivolumab has a positive impact on overall survival in patients with refractory esophageal cancer

Scientific commission

Alexandre Jácome
Alexandre Jácome
Alexandre Palladino
Alexandre Palladino
Gabriel Prolla
Gabriel Prolla
Roberto Gil
Roberto Gil

Contributors

Cintia Elaine Nascimento Givigi
Cintia Elaine Nascimento Givigi
Rafael José Vargas Alves
Rafael José Vargas Alves

This is a scientific newsletter curated by the main medical-scientific content for each specialty and interdisciplinary work between oncology and other areas. Enjoy your reading!

Access the full article of this study
Download
Share
Or share the link
Link copied to your desktop.L